Enact Holdings Inc

New York's FY27 budget law requires 3D printers sold in the state to include firearm-blocking technology, subject to a feasibility review, with a $5,000 penalty for noncompliance.

Reviva Pharmaceuticals Holdings has implemented a 1-for-20 reverse stock split to boost its share price and avoid a Nasdaq delisting, with a critical compliance deadline of March 27. The company also faces financing challenges for an additional Phase 3 trial of its schizophrenia drug candidate, brilaroxazine.